Therefore, Gupta et al.422combined VS and ML to classify the HDAC inhibitors and identified a novel compound that potentially inhibits all isoforms of class I and class IIb HDAC for AD therapy. The gene discussed is HDAC9; the disease is Alzheimer disease.